PhaseRx, Inc.
PZRX
PZRX was delisted on the 2nd of February, 2018.
5 hedge funds and large institutions have $2.14M invested in PhaseRx, Inc. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.
37% more capital invested
Capital invested by funds: $1.56M → $2.14M (+$580K)
38% less funds holding
Funds holding: 8 → 5 (-3)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
+$41.3K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.91K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$619 |
| 4 |
BlackRock
New York
|
+$519 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$847K |
| 2 |
PA
Perceptive Advisors
New York
|
-$310K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$53K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$40K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |
PZRX Hedge Fund Activity: Q1 2017 in Review
5 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in PhaseRx, Inc. (PZRX) for Q1 2017, worth a combined $2.14M — up 37% from $1.56M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PZRX and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Credit Agricole, opening a new position worth an estimated $41.3K. The largest seller was Fidelity Investments, exiting entirely with an estimated $847K sold.
- 5 institutional investors held PhaseRx, Inc. (PZRX) as of Q1 2017, down from 8 in Q4 2016.
- Funds reported $2.14M of PhaseRx, Inc. stock for Q1 2017, up 37% quarter-over-quarter.
- 3 funds opened new PhaseRx, Inc. positions in Q1 2017 and 5 closed out, a net change of -2 holders.
- The largest PhaseRx, Inc. buyer in Q1 2017 was Credit Agricole, an estimated $41.3K added.
- The largest PhaseRx, Inc. seller in Q1 2017 was Fidelity Investments, an estimated $847K sold.
Based on aggregated 13F filings for Q1 2017.